Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. The firm aggregates, incubates, integrates and invests in the natural health product and botanical drug development industry. The company operates through the segment of producing, licensing and marketing ingredients and formulas for use in the biopharma, nutraceutical, cosmetic and animal nutrition markets. The Company, through its subsidiaries, develops and commercializes natural health (nutraceutical) products, and conducts research and development to create plant-based (botanical) intellectual property and ingredients for the pharmaceutical and bioceutical markets, among others. The company offers products and services, such as botanical blends and formulas; cannabidiol ingredients; functional foods and beverages, and analytical services. The company is focused on creating botanical formulations, medical marijuana and specialized health products for pain caused by inflammation, and mental ailments.
根據最新的財務報表(Form-10K),RioCan Real Estate Investment Trust 的總資產為 $0,淨isProfitable}為 $0
ATTBF 的關鍵財務比率是什麼?
RioCan Real Estate Investment Trust 的流動比率為 0,淨利潤率為 0,每股銷售為 $0。
Abattis Bioceuticals Corp 的收入按細分市場或地理位置如何劃分?
RioCan Real Estate Investment Trust 最大收入來源為 Banking and Related Activities,在最近的收益報告中收入為 49,361,000。就地區而言,United States 是 RioCan Real Estate Investment Trust 的主要市場,收入為 49,361,000。
Abattis Bioceuticals Corp 是否盈利?
無,根據最新的財務報表,RioCan Real Estate Investment Trust 的淨損失為 $0